Please check your internet connection and try again.
# Urimax (tamsulosin)
## Overview
Tamsulosin is a selective alpha-1 adrenergic receptor antagonist that preferentially blocks alpha-1A receptors in the prostate and bladder neck, causing smooth muscle relaxation. It is structurally targeted to reduce bladder outlet obstruction with minimal systemic blood pressure effects compared to non-selective alpha-blockers.
## Primary Indications
* Signs and symptoms of benign prostatic hyperplasia (BPH).
* Off-label: Medical expulsive therapy for distal ureteral stones.
## Adult Dosing
* **BPH:** 0.4 mg orally once daily, taken 30 minutes after the same meal each day.
* If no response after 2–4 weeks, dosage may be increased to 0.8 mg daily.
* **Maximum dose:** 0.8 mg daily.
## Pediatric Dosing
* **Not indicated/Not established.** Safety and efficacy have not been established in pediatric patients. Use is generally avoided.
## Dose Adjustments
* **Renal Impairment:** No initial dosage adjustment required.
* **Hepatic Impairment:** Not recommended in patients with severe hepatic impairment (Child-Pugh score >9). Use with caution in moderate impairment.
* **CYP3A4/2D6 Inhibitors:** Use with caution; monitor for increased orthostatic hypotension.
## Contraindications
* Known hypersensitivity to tamsulosin or any component of the formulation.
* History of angioedema.
## Adverse Effects
* **Common:** Dizziness, headache, abnormal ejaculation (retrograde ejaculation), rhinitis, asthenia.
* **Serious:** Orthostatic hypotension (can lead to syncope), Intraoperative Floppy Iris Syndrome (IFIS) during cataract/glaucoma surgery, priapism (rare).
## Key Drug Interactions
* **Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin):** May significantly increase tamsulosin serum concentrations.
* **Strong CYP2D6 inhibitors (e.g., paroxetine):** May increase exposure.
* **PDE-5 Inhibitors (e.g., sildenafil, tadalafil):** Concurrent use may lead to additive blood pressure lowering; initiate at the lowest dose and monitor for symptomatic hypotension.
* **Antihypertensives:** Potential for additive hypotensive effects.
## Monitoring
* Monitor blood pressure periodically, especially upon initiation or dosage escalation.
* Monitor for symptom improvement (e.g., International Prostate Symptom Score).
* Assess for postural dizziness or lightheadedness.
## Clinical Pearls
* **Administration:** Must be swallowed whole. Do not crush, chew, or open the capsule, as this alters the controlled-release mechanism.
* **Timing:** Administer 30 minutes after the same meal every day to minimize variability in absorption.
* **IFIS:** Advise patients to inform their ophthalmologist prior to cataract or glaucoma surgery that they are taking or have taken tamsulosin, as it may cause iris complications during surgery.
* **Fall Risk:** Exercise caution in elderly patients due to the risk of syncope and orthostasis.
***
**Disclaimer:** This information is for educational purposes and does not replace professional clinical judgment. Always verify current prescribing information, institutional protocols, and contraindications before initiating therapy.
